Caring for Our Patients on Opioids: Compassionate Care With
Nonmember Price: 40.00
Member Price: 30.00
40.00
1.0 Category 1-A CME Credits
Kathleen M. Farrell, DO
Disclosure: Disclosure(s): No financial relationships to disclose

We have patients getting opioids with a prescription and patients getting illicit opioids. Many of us do not start patients on opioids, but what do we do with our legacy patients? Treating and managing these patients is challenging. Our guidelines keep evolving.

The United States is 4.2% of the world's population and we are buying 30% of the world's opioids. We are discovering that our use of opioids has increased mental health issues and death rates. At a time when suicide rates are going down in other countries, suicide rates in the United States continue to climb. Does the way we treat our patients on opioids have an impact on these statistics?

This is a dynamic field in patient care. We will be looking at ways to use current guidelines for pain, opioid use disorder and opioid dependence to improve care in our patients on opioids.
Learning Objectives:
Understand alternatives to care for our patients on prescription and illicit opioids. Many of us have inherited "legacy patients" on opioids. We also have patients that have gone to illicit opioids. We may not be able to get these patients to follow our best care plans or use our best treatment options, but we me may be able to get our patients to a safer place by meeting the patient where they are .
Understand guidelines for opioid use disorder by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition; opioid dependence by the World Health Organization; and the use of opioids in chronic pain by the U.S. Department of Health and Human Services and the U.S. Centers for Disease Control and Prevention. Know when and what guideline to use can help you mange your patients so you improve outcomes.
Put the opioid crisis in perspective and what it means to us and how we manage our practice. As we stop prescribing opioids, suicide rates and mental health crises continue to rise. As providers, we are put in a position that allows us to have an impact. Using buprenorphine and methadone in our patients on opioids can save lives.

This program is sponsored by ACOFP for educational purposes only. The material presented is not intended to represent the sole or the best medical interventions for the discussed diagnoses, but rather is intended to present the opinions of the authors or presenters that may be helpful to other practitioners.

Attendees participating in this medical education program do so with the full knowledge that they waive any claim they may have against ACOFP for reliance on any information presented during these educational activities.

The American College of Osteopathic Family Physicians (ACOFP) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.

ACOFP designates this live activity for a maximum of 1.0 AOA Category 1-A CME credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.

To access this course please visit:
https://www.pathlms.com/acofp/courses/45856/sections/55185